ZyVersa Therapeutics, Inc. (ZVSA )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol ZVSA
- Company ZyVersa Therapeutics, Inc.
- Price $0.25
- Changes Percentage -7.84
- Change -0.021
- Day Low $0.24
- Day High $0.27
- Year High $1.94
- Year Low $0.11
- Market Cap $2,023,980
- Price Avg 50 EMA (D) $0.2
- Price Avg 200 EMA (D) $0.25
- Exchange NASDAQ
- Volume 5,098
- Average Volume 79,922
- Open $0.27
- Previous Close $0.27
- EPS -3.32
- PE -0.08
- Earnings Announcement 2026-03-26 20:00:00
- Shares Outstanding $8,095,921
Company brief: ZYVERSA THERAPEUTICS, INC. (ZVSA )
- Healthcare
- Biotechnology
- Mr. Stephen C. Glover
- https://www.zyversa.com
- US
- N/A
- 02-11-2022
- US98987D2018
ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It engages in the development of VAR 200, a cholesterol efflux mediator to treat focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney disease; and IC 100, a novel inflammasome ASC inhibitor for treatment of multitude of inflammatory diseases. ZyVersa Therapeutics, Inc. is headquartered in Weston, Florida.